Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study

Lancet

Volumn 349, Issue 9064, 1997, Pages 1493-1497

  Hall, Alistair S ^a   Murray, Gordon D ^b   Ball, Stephen G ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK; SURVIVAL; UNITED KINGDOM;

EID: 0030995759     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)04442-5     Document Type: Article

References (23)

1. ISIS-4 Collaborative Group. Fourth International Study of Infarct Survival. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.
2. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H on behalf of the CONSENSUS II Study Group. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327: 678-84.
3. Pfeffer MA, Braunwald E, Moyé LA, et al on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669-77.
4. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-28.
5. GISSI-3. (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico). Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.
6. GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Six month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction. J Am Coll Cardiol 1996; 27: 337-44.
7. Ambrosioni E, Borghi C, Magnani B for the Survival of Myocardial Infarction Long-term evaluation (SMILE) Study Investigators. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995; 332: 80-85.
8. Kober L, Torp-Pedersen C, Carlsen JE, et al for the Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-76.
9. Lisheng L, Liu LS, Wang W, et al for the Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995; 345: 686-87.
10. GISSI-3. Study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction. Am J Cardiol 1992; 70: 62C-69.
11. Hall AS. ACE inhibitors post-MI: the case for delayed, selective long-term treatment. Controvers Cardiol 1995; 6 (2): 5-8.
12. Latini R, Maggioni AP, Zuanetti G, Franzosi MG, Tognoni G on behalf of the GISSI-3 investigators. ACE inhibitors post-MI: the case for early, non-selective treatment. Controvers Cardiol 1995; 6 (2): 9-12.
13. The ASPIRE Steering Group. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart 1996, 75: 334-42.
14. Sapsford RJ, Hall AS, Robinson MB. Evaluation of angiotensin-converting enzyme inhibitor dosage and prescription rates in post-myocardial infarction patient. Eur Heart J 1996; 17: 62 (abstr).
15. Selby JV, Fireman BH, Lundstrom RJ, et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med 1996; 335: 1888-96.
16. Hall AS, Ball SG. ACE-inhibitors after myocardial infarction. Lancet 1989; 2: 1527.
17. Hall AS, Winter C, Bogle SM, Mackintosh AF, Murray GD, Ball SG. The Acute Infarction Ramipril Efficacy (AIRE) Study: rationale, design, organization and outcome definitions. J Cardiovasc Pharmacol 1991; 18 (2): S105-09.
18. Cleland JGF, Erhardt L, Hall AS, Winter C, Ball SG on behalf of the AIRE Study Investigators. Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. J Cardiovasc Pharmacol 1993; 22 (9): S22-27.
19. Cleland JGF, Erhardt L, Murray G, Hall AS, Ball SG, on behalf of the AIRE Study Investigators. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Eur Heart J 1997; 18: 41-51.
20. Martinez C, Ball SG. Cost-effectiveness of ramipril therapy for patients with clinical evidence of heart failure after acute myocardial infarction. Br J Clin Pract 1995; 49 (78): S26-32.
21. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
22. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10 year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-70.
23. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.